Similar articles

• AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.

  Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G. Balkhi MY, et al. Exp Hematol. 2008 Nov;36(11):1449-60. doi: 10.1016/j.exphem.2008.05.008. Epub 2008 Aug 8. Exp Hematol. 2008. PMID: 18687517
• The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.

  Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G. Elsässer A, et al. Oncogene. 2003 Aug 28;22(36):5646-57. doi: 10.1038/sj.onc.1206673. Oncogene. 2003. PMID: 12944913
• ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.

  Lausen J, Liu S, Fliegauf M, Lübbert M, Werner MH. Lausen J, et al. Oncogene. 2006 Mar 2;25(9):1349-57. doi: 10.1038/sj.onc.1209181. Oncogene. 2006. PMID: 16247445
• ETO interacting proteins.

  Hug BA, Lazar MA. Hug BA, et al. Oncogene. 2004 May 24;23(24):4270-4. doi: 10.1038/sj.onc.1207674. Oncogene. 2004. PMID: 15156183 Review.
• Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.

  Nimer SD, Moore MA. Nimer SD, et al. Oncogene. 2004 May 24;23(24):4249-54. doi: 10.1038/sj.onc.1207673. Oncogene. 2004. PMID: 15156180 Review.